Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality
Using vaccination conversations to empower and engage adolescents
+Practice
In print
Vaccines
Using vaccination conversations to empower and engage adolescents
Wednesday 11 December 2024, 12:35 AM

Meningococcal disease cases by age group, 2024 (as of 31 October) [Data from ESR, tinyurl.com/men-dashboard]
This article emphasises why conversations with young people about vaccines must be a priority in general practice
Key points, Take time to get to know the young person in front of you and tailor communication to their stage of brain development.
Ensure every interaction is , Pract Green w Pale Yellow
References
1. Burman C, Serra L, Nuttens C, et al. Meningococcal disease in adolescents and young adults: a review of the rationale for prevention through vaccination. Hum Vaccin Immunother 2019;15(2):459–69.
2. Nowlan M. Review of evidence to inform New Zealand National Immunisation Programme, 2023: Human papillomavirus. IMAC; August 2023.
3. Cameron RL, Palmer TJ, Cuschieri K, et al. Assessing real world vaccine effectiveness: A review of Scotland’s approach to monitoring human papillomavirus (HPV) vaccine impact on HPV infection and cervical disease. Vaccine 2024;42(21):126177.